7 results mentionning IRB approval 2020-021 X # DOI Title Journal Date Cited/self/% Refs/self/% IRB Funding Notes 1 10.1016/j.ijid.2020.10.067 Asymptomatic Hypoxia In COVID-19 Is Associated With Poor Outcome International Journal of infectious Diseases 2021-01 86/6/7% 16/3/19% 2020-021 Reviewed in 29 days Email sent to the editor 2 10.1016/j.tmaid.2020.101791 Outcomes Of 3,737 COVID-19 Patients Treated With Hydroxychloroquine/Azithromycin And Other Regimens In Marseille, France: A Retrospective Analysis Travel Medicine and Infectious Disease 2020-07 203/43/21% 33/7/21% 2020-021 Reviewed in 18 days Email sent to the editor 3 10.1038/s41418-021-00817-9 Prolonged SARS-CoV-2 RNA Virus Shedding And Lymphopenia Are Hallmarks Of COVID-19 In Cancer Patients With Poor Prognosis Cell Death & Differentiation 2021-07-06 27/8/30% 72/15/21% 2020-021 Email sent to the editor 4 10.21203/rs.3.rs-251817/v1 The Need for Early Management in Patients With COVID-19 Research Square 2021-02-25 2020-021 Email sent to the editor 5 10.3390/jcm10122696 Isolation Of Viable SARS-CoV-2 Virus From Feces Of An Immunocompromised Patient Suggesting A Possible Fecal Mode Of Transmission Journal of Clinical Medicine 2021-06-18 33/3/9% 26/10/38% 2020-021 Email sent to the editor 6 10.3390/v13050890 SARS-CoV-2 Persistent Viral Shedding In The Context Of Hydroxychloroquine-Azithromycin Treatment Viruses 2021-05-12 7/3/43% 38/7/18% 2020-021 Email sent to the editor 7 https://www.mediterranee-infection.com/wp-content/uploads/2020/09/Camoin-Jau-et-al-.pdf High prevalence of Lupus Anticoagulant in Ambulatory COVID-19 patients: interest of Hydroxychloroquine ? Preprint 2020-09 2020-021 Healthy Patients X Article IRB IRB Approval